LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

WANBURY

NSEBSE
Wanbury Limited
Healthcare· Pharmaceuticals & Biotechnology· INE107F01022· Scrip: 524212
ENहिन्दीગુજરાતીमराठी
263.30
3.60 (+1.39%)
20/4/2026, 10:29:40 pm
NSE
263.30
3.60
+1.39%
BSE
257.65
2.70
+0.00%
16320023827631405-0206-2708-2510-2312-1902-1804-2704-30
244 trading days · 1Y period
TODAY
Open261.99
High269.00
Low256.00
Prev Close259.70
Volume3.49Cr
Value₹0.0Cr
L: 256.00H: 269.00
52 WEEK
Low161.50
High329.70
61% of 52W range
Info
Face Value₹10
Listed2007-01-29
ISININE107F01022
SeriesT
BSE Scrip524212

Key Metrics

1D
-1.15%
1W
-2.57%
1M
+4.90%
3M
+28.42%
6M
+10.94%
Valuation
Mkt Cap₹810 Cr
Growth (QoQ)
Revenue-17.21%
PAT-84.81%
EPS-68.85%
Dividend
Yield0.39%
TTM Revenue
₹565 Cr
TTM EBITDA
₹58 Cr
TTM PAT
₹44 Cr
TTM EPS
₹16.27
Rev/Share
₹161.8

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr40 Cr81 Cr121 Cr161 Cr22-1223-0323-0923-1224-0324-0624-0924-12-1.00.82.33.112.80.32.40.8
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31133 Cr133 Cr5 Cr1 Cr1 Cr0.76
2024-09-30161 Cr155 Cr11 Cr8 Cr8 Cr2.44
2024-06-30131 Cr131 Cr4 Cr1 Cr1 Cr0.32
2024-03-31139 Cr132 Cr37 Cr34 Cr34 Cr12.75
2023-12-31145 Cr136 Cr14 Cr10 Cr10 Cr3.13
2023-09-30144 Cr138 Cr10 Cr7 Cr7 Cr2.25
2023-03-31133 Cr129 Cr4 Cr1 Cr1 Cr0.80
2022-12-31126 Cr129 Cr0 Cr-3 Cr-3 Cr-1.00

Shareholding Pattern

CURRENT2026-03-31
43.0%PROMOTER
Promoter43.0%
FII0.6%
Public57.0%
PROMOTER HOLDING TREND
39.8%24-0939.8%24-1239.8%25-0343.1%25-0943.1%25-1243.0%26-03

Corporate Actions

Ex-DateTypePurpose
2024-09-20OtherAnnual General Meeting
2023-11-10OtherExtra Ordinary General Meeting
2023-09-20OtherAnnual General Meeting
2023-08-14OtherExtra-Ordinary General Meeting
2022-09-20OtherAnnual General Meeting
2021-09-17Other Annual General Meeting
2021-03-10Other Extra Ordinary General Meeting
2020-09-18Other Annual General Meeting
2019-09-20Other Annual General Meeting
2018-09-18Other Annual General Meeting
2017-09-21Other Annual General Meeting
2016-09-21Other Annual General Meeting
2015-09-18Other Annual General Meeting
2015-03-12OtherAnnual General Meeting
2013-09-26OtherAnnual Book Closure
2012-09-13OtherAnnual General Meeting
2011-09-19OtherAnnual General Meeting
2010-07-29DividendDividend-Rs.1/- Per Share
2009-09-17OtherAnnual General Meeting
2009-03-12DividendAgm/Dividend - 5%

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-04-30259.80259.80253.03254.2819,173
2026-04-29261.00264.00255.20257.9639,478
2026-04-28260.08263.90258.00259.8517,235
2026-04-27262.00268.00258.00259.2222,849
2026-04-24255.10266.00253.50258.2223,610
2026-04-23268.90268.99256.19261.7239,112
2026-04-22260.00271.22254.30269.6782,504
2026-04-21261.84266.69255.10258.3118,723
2026-04-20261.99269.00256.00261.8439,082
2026-04-17258.00266.00252.45259.7083,393
2026-04-16277.65277.65263.00265.731.52L
2026-04-15255.25264.43255.25264.4338,627
2026-04-13240.21256.25234.00251.8465,433
2026-04-10233.45245.12231.00245.1280,522
2026-04-09235.60241.00228.50233.4522,139
2026-04-08231.00234.17229.00234.1742,643
2026-04-07228.00231.80220.50223.0249,960
2026-04-02226.98234.00222.00230.3958,855
2026-04-01232.87233.04225.00230.4269,428
2026-03-27240.80240.80225.80226.8567,882
2026-03-25244.00251.00233.50237.6549,848
2026-03-24243.00244.20238.10243.1014,546
2026-03-20247.95252.00245.80248.3027,892
2026-03-19253.95253.95238.55240.7066,859
2026-03-18248.90260.00245.60249.3536,771
2026-03-17247.10249.00238.10247.7532,323
2026-03-16248.00248.00237.35247.1038,839
2026-03-13257.35265.35247.10249.8046,145
2026-03-12240.20257.35238.00257.3536,873
2026-03-11248.80248.80242.50245.1012,845

Frequently Asked Questions

About

Wanbury Limited is an Indian pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and domestic branded formulations, with a global presence in the APIs market. The company focuses on research and pharmaceutical-related activities, positioning itself as a key player in the industry. Established in 1992, Wanbury Limited has been recognized for its contributions to the pharmaceutical sector through innovation and quality.

BOARD OF DIRECTORS